Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 1524172
[patent_doc_number] => 06353024
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-05
[patent_title] => 'Method for preventing and treating arthritis, osteo-traumatic pain, and neuralgias with trimebutine'
[patent_app_type] => B1
[patent_app_number] => 09/490093
[patent_app_country] => US
[patent_app_date] => 2000-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 9969
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/353/06353024.pdf
[firstpage_image] =>[orig_patent_app_number] => 09490093
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/490093 | Method for preventing and treating arthritis, osteo-traumatic pain, and neuralgias with trimebutine | Jan 23, 2000 | Issued |
Array
(
[id] => 4326162
[patent_doc_number] => 06329339
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-11
[patent_title] => 'Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity'
[patent_app_type] => 1
[patent_app_number] => 9/423611
[patent_app_country] => US
[patent_app_date] => 2000-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2470
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/329/06329339.pdf
[firstpage_image] =>[orig_patent_app_number] => 423611
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/423611 | Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity | Jan 17, 2000 | Issued |
Array
(
[id] => 4304851
[patent_doc_number] => 06187791
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-13
[patent_title] => 'Method of providing an antihistaminic effect in a hepatically impaired patient'
[patent_app_type] => 1
[patent_app_number] => 9/481404
[patent_app_country] => US
[patent_app_date] => 2000-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1784
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/187/06187791.pdf
[firstpage_image] =>[orig_patent_app_number] => 481404
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/481404 | Method of providing an antihistaminic effect in a hepatically impaired patient | Jan 11, 2000 | Issued |
Array
(
[id] => 4416798
[patent_doc_number] => 06177077
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-23
[patent_title] => 'TNT inhibitors for the treatment of neurological disorders'
[patent_app_type] => 1
[patent_app_number] => 9/476643
[patent_app_country] => US
[patent_app_date] => 1999-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6111
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/177/06177077.pdf
[firstpage_image] =>[orig_patent_app_number] => 476643
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/476643 | TNT inhibitors for the treatment of neurological disorders | Dec 30, 1999 | Issued |
Array
(
[id] => 4371352
[patent_doc_number] => 06288089
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-11
[patent_title] => 'Use of kinase inhibitors for treating neurodegenerative diseases'
[patent_app_type] => 1
[patent_app_number] => 9/469980
[patent_app_country] => US
[patent_app_date] => 1999-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 16932
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 1313
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/288/06288089.pdf
[firstpage_image] =>[orig_patent_app_number] => 469980
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/469980 | Use of kinase inhibitors for treating neurodegenerative diseases | Dec 20, 1999 | Issued |
Array
(
[id] => 4353914
[patent_doc_number] => 06291527
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-18
[patent_title] => 'Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application'
[patent_app_type] => 1
[patent_app_number] => 9/445672
[patent_app_country] => US
[patent_app_date] => 1999-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6108
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/291/06291527.pdf
[firstpage_image] =>[orig_patent_app_number] => 445672
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/445672 | Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application | Dec 9, 1999 | Issued |
Array
(
[id] => 4329474
[patent_doc_number] => 06319953
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-20
[patent_title] => 'Treatment of depression and anxiety with fluoxetine and an NK-1 receptor antagonist'
[patent_app_type] => 1
[patent_app_number] => 9/457241
[patent_app_country] => US
[patent_app_date] => 1999-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 19662
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/319/06319953.pdf
[firstpage_image] =>[orig_patent_app_number] => 457241
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/457241 | Treatment of depression and anxiety with fluoxetine and an NK-1 receptor antagonist | Dec 7, 1999 | Issued |
60/304199 | NOVEL METHODS AND COMPOSITIONS INVOLVING OPIOIDS AND ANTAGONISTS THEREOF | Nov 28, 1999 | Pending |
Array
(
[id] => 1566894
[patent_doc_number] => 06376513
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-23
[patent_title] => 'Drug for relieving pain and promoting the removal of calculi in urolithiasis'
[patent_app_type] => B1
[patent_app_number] => 09/448422
[patent_app_country] => US
[patent_app_date] => 1999-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 2226
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/376/06376513.pdf
[firstpage_image] =>[orig_patent_app_number] => 09448422
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/448422 | Drug for relieving pain and promoting the removal of calculi in urolithiasis | Nov 23, 1999 | Issued |
Array
(
[id] => 1533197
[patent_doc_number] => 06410560
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-25
[patent_title] => 'Drug for relieving pain and promoting the removal of calculi in urolithiasis'
[patent_app_type] => B1
[patent_app_number] => 09/448423
[patent_app_country] => US
[patent_app_date] => 1999-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 2227
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/410/06410560.pdf
[firstpage_image] =>[orig_patent_app_number] => 09448423
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/448423 | Drug for relieving pain and promoting the removal of calculi in urolithiasis | Nov 23, 1999 | Issued |
Array
(
[id] => 6064240
[patent_doc_number] => 20020032219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-14
[patent_title] => 'USE OF ALPHA-1C SPECIFIC COMPOUNDS TO TREAT BENIGN PROSTATIC HYPERPLASIA'
[patent_app_type] => new
[patent_app_number] => 09/444783
[patent_app_country] => US
[patent_app_date] => 1999-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11241
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20020032219.pdf
[firstpage_image] =>[orig_patent_app_number] => 09444783
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/444783 | Use of 1C specific compounds to treat benign prostatic hyperplasia | Nov 21, 1999 | Issued |
Array
(
[id] => 4171372
[patent_doc_number] => 06140335
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-31
[patent_title] => 'Use of mizolastine for treating inflammatory diseases associated with 5-lipoxygenase'
[patent_app_type] => 1
[patent_app_number] => 9/403005
[patent_app_country] => US
[patent_app_date] => 1999-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1402
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/140/06140335.pdf
[firstpage_image] =>[orig_patent_app_number] => 403005
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/403005 | Use of mizolastine for treating inflammatory diseases associated with 5-lipoxygenase | Nov 18, 1999 | Issued |
Array
(
[id] => 4356453
[patent_doc_number] => 06200983
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-13
[patent_title] => 'Dosage forms containing apomorphine for ameliorating male erectile dysfunction'
[patent_app_type] => 1
[patent_app_number] => 9/440451
[patent_app_country] => US
[patent_app_date] => 1999-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11091
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/200/06200983.pdf
[firstpage_image] =>[orig_patent_app_number] => 440451
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/440451 | Dosage forms containing apomorphine for ameliorating male erectile dysfunction | Nov 14, 1999 | Issued |
Array
(
[id] => 1475036
[patent_doc_number] => 06387907
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-14
[patent_title] => 'Use of serotonin agonists to alleviate disordered breathing episodes in a mammal'
[patent_app_type] => B1
[patent_app_number] => 09/439799
[patent_app_country] => US
[patent_app_date] => 1999-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 26
[patent_no_of_words] => 11913
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/387/06387907.pdf
[firstpage_image] =>[orig_patent_app_number] => 09439799
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/439799 | Use of serotonin agonists to alleviate disordered breathing episodes in a mammal | Nov 11, 1999 | Issued |
Array
(
[id] => 1560459
[patent_doc_number] => 06436997
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-20
[patent_title] => 'Endogenous nitric oxide synthesis under conditions of low oxygen tension'
[patent_app_type] => B1
[patent_app_number] => 09/429020
[patent_app_country] => US
[patent_app_date] => 1999-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 11525
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/436/06436997.pdf
[firstpage_image] =>[orig_patent_app_number] => 09429020
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/429020 | Endogenous nitric oxide synthesis under conditions of low oxygen tension | Oct 28, 1999 | Issued |
09/425229 | OMEGA-CARBOXY ARYL SUDSTITUTED DIPHENYL UREAS AS P38 KINASE INHIBITORS | Oct 21, 1999 | Abandoned |
Array
(
[id] => 4320780
[patent_doc_number] => 06328997
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-11
[patent_title] => 'Aqueous metal bicarbonate solution and method of use'
[patent_app_type] => 1
[patent_app_number] => 9/422645
[patent_app_country] => US
[patent_app_date] => 1999-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 26551
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/328/06328997.pdf
[firstpage_image] =>[orig_patent_app_number] => 422645
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/422645 | Aqueous metal bicarbonate solution and method of use | Oct 21, 1999 | Issued |
Array
(
[id] => 4380744
[patent_doc_number] => 06303645
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-16
[patent_title] => 'Benzimidazole derivatives as modulators of IgE'
[patent_app_type] => 1
[patent_app_number] => 9/422397
[patent_app_country] => US
[patent_app_date] => 1999-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6020
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/303/06303645.pdf
[firstpage_image] =>[orig_patent_app_number] => 422397
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/422397 | Benzimidazole derivatives as modulators of IgE | Oct 20, 1999 | Issued |
Array
(
[id] => 4206682
[patent_doc_number] => 06077869
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-06-20
[patent_title] => 'Aryl phenylhydrazides as selective COX-2 inhibitors for treatment of inflammation'
[patent_app_type] => 1
[patent_app_number] => 9/421566
[patent_app_country] => US
[patent_app_date] => 1999-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2261
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/077/06077869.pdf
[firstpage_image] =>[orig_patent_app_number] => 421566
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/421566 | Aryl phenylhydrazides as selective COX-2 inhibitors for treatment of inflammation | Oct 19, 1999 | Issued |
Array
(
[id] => 4260164
[patent_doc_number] => 06204245
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-20
[patent_title] => 'Treatment of narcolepsy with immunosuppressants'
[patent_app_type] => 1
[patent_app_number] => 9/398260
[patent_app_country] => US
[patent_app_date] => 1999-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 10762
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/204/06204245.pdf
[firstpage_image] =>[orig_patent_app_number] => 398260
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/398260 | Treatment of narcolepsy with immunosuppressants | Sep 16, 1999 | Issued |